400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
ChiCTR1900025550
正在进行
/
/
/
2019-08-31
/
/
精神分裂症
Concurrent Transcranial Direct Current Stimulation with Cognitive Training for Cognitive Functions of Schizophrenia Patients
A Randomised Controlled Trial of Online Transcranial Direct Current Stimulation (tDCS) in Enhancing the Effects of Cognitive Training in patients with Schizophrenia
The primary objective of the study is to investigate the adjunct effect of online tDCS with cognitive training on specific cognitive domains in stable schizophrenia patients. (i) right after the intervention (ii) whether maintenance effect at 1 month after intervention. The secondary objective of the study is to probe (i) any effects on affective , psychotic and negative symptoms; (ii) psychosocial functioning, subjective quality of life (QOL); (iii) the motivation and enjoyment of continuing playing the computerized cognitive training; (iv) the tolerability and adverse events of tDCS among patients with schizophrenia.
随机平行对照
治疗新技术
The subjects will be randomly allocated to the intervention group or the control group by a block randomization procedure (1:1 allocation) . The randomization sequence will be generated by an online randomization tool (www.sealedenvelop.com) .
Double Blind
N/A
/
16
/
2019-08-01
2020-06-30
/
1. Patients receiving rehabilitation service in Tai Po Hospital aged between 18-65 years old; 2. diagnosis of schizophrenia meeting the diagnostic criteria of the World Health Organizations 10thversion of the International Statistical Classification of Disease and Related Health Problems (ICD-10),it will be made clinically by the study psychiatrist based on ICD-10; 3. right-handedness; 4. able to understand spoken instructions in Cantonese and able to read traditional Chinese.;
请登录查看1. History of significant head trauma; 2. active abuse of alcohol or illegal substances; 3. significant neurologic history such as dementia, stroke, seizure, Parkinsons disease, multiple sclerosis; 4. concurrent use of cognitive-enhancing medications e.g. acetylcholinesterase inhibitors ; 5. documented history of learning disability; f. implanted with pacemakers, intracranial electrodes, defibrillators; g. changes in medication regime over the 2 weeks before or during the study period.;
请登录查看香港中文大學大埔醫院
/
IONOVA2025-12-05
复宏汉霖2025-12-05
鞍石生物Avistone2025-12-05
英百瑞生物2025-12-05
艾力斯医药科技2025-12-05
神曦生物NeuExcell2025-12-05
科望医药2025-12-05
宠药生态圈2025-12-05
丁香园 Insight 数据库2025-12-05
佰傲谷BioValley2025-12-05